Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats.
Protinhi Therapeutics has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in October 2022.
Protinhi Therapeutics's investors include European Innovation Council.
Protinhi Therapeutics is headquartered in Nijmegen, The Netherlands.
Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats.
Protinhi Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Protinhi Therapeutics — Funding & Investors." VCBacked, October 5, 2022, https://www.vcbacked.co/company/protinhi-therapeutics. Accessed July 22, 2026.
VCBacked. (2022). Protinhi Therapeutics — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/protinhi-therapeutics
{{cite web |title=Protinhi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/protinhi-therapeutics |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated